Stephens Inc. AR increases its stake in DR Horton, Inc. (NYSE: DHI)


Stephens Inc. AR increased its stake in DR Horton, Inc. (NYSE: DHIGet a rating) by 13.9% during the 1st quarter, according to its last filing with the Securities and Exchange Commission (SEC). The fund held 6,495 shares of the construction company after buying an additional 792 shares during the period. Stephens Inc. AR’s holdings in DR Horton were worth $484,000 as of the date of its last filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently increased or reduced their stakes in the company. Larson Financial Group LLC increased its holdings in DR Horton by 65.4% in the fourth quarter. Larson Financial Group LLC now owns 311 shares of the construction company worth $34,000 after acquiring 123 additional shares in the last quarter. Confluence Wealth Services Inc. acquired a new stake in DR Horton in the fourth quarter worth approximately $37,000. Sandy Cove Advisors LLC acquired a new stake in DR Horton in the fourth quarter worth approximately $43,000. GPS Wealth Strategies Group LLC increased its holdings in DR Horton by 300.0% in the first quarter. GPS Wealth Strategies Group LLC now owns 400 shares of the construction company worth $30,000 after acquiring 300 additional shares in the last quarter. Finally, Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. acquired a new stake in DR Horton in the fourth quarter worth approximately $51,000. Hedge funds and other institutional investors own 81.27% of the company’s shares.

DR Horton stock performance

Shares of DR Horton Stock opened at $74.22 on Thursday. DR Horton, Inc. has a 52-week low of $59.25 and a 52-week high of $110.45. The company’s fifty-day simple moving average is $71.65 and its 200-day simple moving average is $76.32. The company has a market capitalization of $25.79 billion, a PE ratio of 4.77, a growth price-earnings ratio of 0.55 and a beta of 1.60. The company has a quick ratio of 0.84, a current ratio of 5.71 and a debt ratio of 0.32.

DR Horton (NYSE: DHIGet a rating) last announced its quarterly results on Thursday, July 21. The construction company reported EPS of $4.67 for the quarter, beating the consensus estimate of $4.49 by $0.18. DR Horton had a return on equity of 33.33% and a net margin of 17.42%. The company posted revenue of $8.79 billion for the quarter, versus analyst estimates of $8.91 billion. In the same quarter a year earlier, the company posted EPS of $3.06. The company’s quarterly revenue increased 20.6% year over year. Stock analysts expect DR Horton, Inc. to post earnings per share of 17.05 for the current year.

DR Horton Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 11. Investors of record on Thursday August 4 will receive a dividend of $0.225 per share. This represents an annualized dividend of $0.90 and a yield of 1.21%. The ex-dividend date is Wednesday, August 3. DR Horton’s payout ratio is 5.78%.

Insider buying and selling

In related news, VP Aron M. Odom sold 5,000 shares in a trade dated Friday, July 22. The stock was sold at an average price of $77.72, for a total transaction of $388,600.00. Following the transaction, the vice president now owns 3,024 shares of the company, valued at approximately $235,025.28. The transaction was disclosed in an SEC filing, which is available via this hyperlink. In other DR Horton news, director Michael W. Hewatt sold 1,948 shares of the company in a trade dated Wednesday, May 25. The stock was sold at an average price of $67.97, for a total transaction of $132,405.56. Following the sale, the director now owns 5,067 shares of the company, valued at approximately $344,403.99. The sale was disclosed in an SEC filing, which is available via the SEC website. Additionally, Vice Chairman Aron M. Odom sold 5,000 shares of the company in a transaction dated Friday, July 22. The stock was sold at an average price of $77.72, for a total value of $388,600.00. Following the sale, the vice president now owns 3,024 shares of the company, valued at approximately $235,025.28. Disclosure of this sale can be found here. In the past 90 days, insiders have sold 10,948 shares of the company valued at $829,286. Company insiders own 0.49% of the company’s shares.

Analysts set new price targets

A number of research companies have recently commented on DHI. JPMorgan Chase & Co. cut its price target on DR Horton from $82.50 to $80.00 and set an “overweight” rating for the company in a Tuesday, July 12 report. Wells Fargo & Company cut its price target on DR Horton from $86.00 to $73.00 and set an “overweight” rating for the company in a Friday, June 17 report. JMP Securities cut its price target on DR Horton from $120.00 to $95.00 and set a “market outperformance” rating for the company in a Friday, July 22 report. UBS Group lowered its price target on DR Horton from $151.00 to $105.00 and set a “buy” rating for the company in a Thursday, June 16 report. Finally, Royal Bank of Canada reduced its price target on DR Horton from $103.00 to $89.00 in a research report on Wednesday, April 27. Four investment analysts gave the stock a hold rating, nine issued a buy rating and one gave the company’s stock a strong buy rating. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $95.14.

DR Horton Company Profile

(Get a rating)

DR Horton, Inc operates as a residential construction company in the eastern, northern, southeast, south-central, southwest, and northwest regions of the United States. It deals with the acquisition and development of land; and building and selling residential homes in 31 states and 98 markets under the DR names

See also

Want to see which other hedge funds hold DHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DR Horton, Inc. (NYSE: DHIGet a rating).

Institutional ownership by quarter for DR Horton (NYSE:DHI)



Get news and reviews for DR Horton Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for DR Horton and related companies with MarketBeat.com’s FREE daily newsletter.

Comments are closed.